0000002019-01-012019-03-310000002019-03-310000002018-04-012019-03-310000002019-01-012019-03-31in-bse-fin:OtherExpenses1Member0000002019-01-012019-03-31in-bse-fin:OtherExpenses2Member0000002018-04-012019-03-31in-bse-fin:OtherExpenses1Member0000002018-04-012019-03-31in-bse-fin:OtherExpenses2Member0000002019-01-012019-03-31ItemsThatWillNotBeReclassifiedToProfitAndLoss10000002019-01-012019-03-31ItemsThatWillNotBeReclassifiedToProfitAndLoss20000002018-04-012019-03-31ItemsThatWillNotBeReclassifiedToProfitAndLoss10000002018-04-012019-03-31ItemsThatWillNotBeReclassifiedToProfitAndLoss20000002019-01-012019-03-31ItemsThatWillBeReclassifiedToProfitAndLoss10000002018-04-012019-03-31ItemsThatWillBeReclassifiedToProfitAndLoss1iso4217:INRiso4217:INRxbrli:shares000000DALMIAREFINE200F01017DALMIA REFRACTORIES LIMITEDEquity2018-04-012019-03-312019-05-242019-05-17INRLakhsYearlySingle segmentManufacturing and sale of Refractory2019-05-2413:30:002019-05-2418:45:00Declaration of unmodified opinion2019-01-012019-03-31AuditedConsolidated0000000000000000000000000000000018636440000000002018-01-042019-03-31AuditedConsolidated2414204000460310002460235000134845900040980000-497310003571850003140000010777600056541500024014840005875100005875100061480000-4220000019280000039471000000039471000-303718000-26424700056451000-16980000-303718000-2472670003152100010186364400017.9117.910017.9117.91Power & Fuel0Other Expenditure0Power & Fuel149457000Other Expenditure41595800013313520001709910002659830004790040006917370009446000680007012510002948581000747719000300006129940003086580001739100022501000715000962289000273600016534200018780860004826667000315210001863644000189516500028201000192336600096480700047945000101275200034169000188126000123504700041557300063674900018996300012422850003906750001172800023566000166825400029033010004826667000Fair value of Equity Instruments0Re- Measurements gain/loss on defined benefit plans00Fair value of Equity Instruments-312774000Re- Measurements gain/loss on defined benefit plans-1324000-31409800000Exchange difference in translating the financial statements of foreign subsidiaries00Exchange difference in translating the financial statements of foreign subsidiaries103800001038000000